Molecular determinants of chaperone interactions on MHC-I for folding and antigen repertoire selection. by McShan, Andrew C et al.
UC Santa Cruz
UC Santa Cruz Previously Published Works
Title
Molecular determinants of chaperone interactions on MHC-I for folding and antigen 
repertoire selection.
Permalink
https://escholarship.org/uc/item/9p37g0zf
Journal
Proceedings of the National Academy of Sciences of the United States of America, 
116(51)
ISSN
0027-8424
Authors
McShan, Andrew C
Devlin, Christine A
Overall, Sarah A
et al.
Publication Date
2019-12-03
DOI
10.1073/pnas.1915562116
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Molecular determinants of chaperone interactions on
MHC-I for folding and antigen repertoire selection
Andrew C. McShana,1, Christine A. Devlinb,c,1, Sarah A. Overalla, Jihye Parkb,c, Jugmohit S. Toora, Danai Moschidia,
David Flores-Solisa,2, Hannah Choib,c, Sarvind Tripathia, Erik Prockob,c,3, and Nikolaos G. Sgourakisa,3
aDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064; bDepartment of Biochemistry, University of Illinois, Urbana,
IL 61801; and cCancer Center at Illinois, University of Illinois, Urbana, IL 61801
Edited by Peter Cresswell, Yale University, New Haven, CT, and approved November 8, 2019 (received for review September 9, 2019)
The interplay between a highly polymorphic set of MHC-I alleles
and molecular chaperones shapes the repertoire of peptide anti-
gens displayed on the cell surface for T cell surveillance. Here, we
demonstrate that the molecular chaperone TAP-binding protein related
(TAPBPR) associateswith a broad range of partially foldedMHC-I species
inside the cell. Bimolecular fluorescence complementation and
deep mutational scanning reveal that TAPBPR recognition is polarized
toward the α2 domain of the peptide-binding groove, and depends on
the formation of a conservedMHC-I disulfide epitope in the α2 domain.
Conversely, thermodynamic measurements of TAPBPR binding for a
representative set of properly conformed, peptide-loaded molecules
suggest a narrower MHC-I specificity range. Using solution NMR, we
find that the extent of dynamics at “hotspot” surfaces confers TAPBPR
recognition of a sparsely populated MHC-I state attained through a
global conformational change. Consistently, restriction ofMHC-I groove
plasticity through the introduction of a disulfide bond between the
α1/α2 helices abrogates TAPBPR binding, both in solution and on a
cellular membrane, while intracellular binding is tolerant of many
destabilizing MHC-I substitutions. Our data support parallel TAPBPR
functions of 1) chaperoning unstable MHC-I molecules with broad
allele-specificity at early stages of their folding process, and 2) editing
the peptide cargo of properly conformed MHC-I molecules en route to
the surface, which demonstrates a narrower specificity. Our results
suggest that TAPBPR exploits localized structural adaptations, both
near and distant to the peptide-binding groove, to selectively recog-
nize discrete conformational states sampled by MHC-I alleles, toward
editing the repertoire of displayed antigens.
major histocompatibility complex | molecular chaperone | peptide
repertoire | NMR spectroscopy | peptide editing
Class I major histocompatibility complex (MHC-I) moleculesdisplay a diverse set of 8 to 14 residue peptide antigens to
CD8+ cytotoxic T lymphocytes (1). This process provides a
means for immune surveillance of the endogenous proteome to
detect invading pathogens or developing tumors. MHC-I molecules
are extremely polymorphic, with thousands of known human
alleles, categorized in the HLA-A, -B, and -C classes. Specific
interactions with highly polymorphic pockets along the peptide
binding groove (termed A- to F-pockets) define a repertoire of up
to 104 peptide antigens that can bind to each HLA protein (1).
Proper folding of nascent MHC-I molecules and loading with
high-affinity peptides requires association with an invariant
light-chain, β2-microglobulin (β2m), and is facilitated by dedi-
cated molecular chaperones, tapasin, which is restricted within
the peptide-loading complex (PLC), and the homologous,
PLC-independent TAPBPR (TAP-binding protein related) (2,
3). Furthermore, through the catalytic enhancement of peptide
association and dissociation within the MHC-I groove, chaper-
ones can influence the selection of immunodominant antigens by
promoting the exchange of low- and intermediate-affinity for
high-affinity peptides (termed “peptide editing”) (2, 3). Further
quality control and narrowing of the displayed antigen repertoire
along the trafficking pathway is accomplished through the
combined functions of TAPBPR and UDP-glucose:glycoprotein
glucosyltransferase (UGGT) (3–5). The discovery that TAPBPR
can function as a peptide-exchange catalyst outside the peptide-
loading complex and can maintain empty MHC-I molecules in a
peptide-receptive conformation has opened a new window to study
the peptide-loading process in a range of detailed functional and
mechanistic studies (4, 6, 7).
Improper function of the antigen processing and presentation
pathway confers susceptibility to diseases in a manner that is
highly dependent on the individual’s MHC-I haplotype and the
disease-relevant immunodominant peptides (8). Several stud-
ies have provided key insights into the allelic preferences of
chaperone interactions. It has been long established that some
MHC-I alleles require tapasin for proper peptide loading,
trafficking, and cell surface display, while others can intrinsically
load peptides in tapasin knockouts (4, 6–10). In an extreme case
demonstrated by the HLA-B*44 alleles, a single amino acid
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polymorphism at the F-pocket is sufficient to switch between
chaperone-dependent and -independent peptide loading (11–13).
Similarly, TAPBPR expression exhibits a marked effect on the
displayed repertoire of specific alleles (4). While structure-based
modeling using the available cocrystal structures as templates can
provide some clues for the molecular basis of MHC-I allelic
dependence of chaperone interactions, molecular dynamics
(MD) simulations, and hydrogen deuterium exchange experiments
have further shown that chaperone-dependent and -independent
alleles exhibit widespread differences in their dynamic profiles (14,
15). In particular, these experiments have suggested the rate of
sampling of an “open” conformation confers chaperone recognition
of different MHC-I alleles (16, 17).
Here, using the chaperone TAPBPR as a model, we apply a
range of complementary functional and biophysical experiments
using fusion and recombinant proteins in a native cellular context
and in solution, respectively. We find that TAPBPR interacts
broadly with nascent MHC-I of varying sequences within cellular
compartments, with a binding mode that is highly polarized
toward the α2 side of the peptide-binding groove, and chaperones
misfolded molecules. However, interactions with properly conformed
pMHC-I molecules toward editing of the peptide cargo are restricted
to a limited set of alleles, where the dynamic sampling of a sparse
minor-state conformation in solution is important. Our results pro-
vide a molecular blueprint for the design of MHC-I molecules with
improved antigen processing and presentation properties, through
the engineering of conformational states across the entire folding
landscape.
Results
TAPBPR Associates with a Broad Range of MHC-I Alleles inside the
Cell. TAPBPR has been reported to exhibit a narrow MHC-I
allele specificity (4, 7). However, it remains undetermined
whether the allelic preferences of TAPBPR manifest in a similar
manner for nascent, empty MHC-I, or properly conformed,
peptide-loaded MHC-I molecules. To explore these concepts
further, we first investigated the propensity for TAPBPR to
interact with MHC-I molecules composed of different heavy-
chain sequences (mouse H2 or human HLA) in a native cellular
environment. We adapted established bimolecular fluorescence
complementation (BiFC) assays in human Expi293F cells trans-
fected using gene constructs containing TAPBPR fused to the
C-terminal half (VC) of split fluorescent Venus, and either of a
panel of heavy-chain MHC-I fused to the N-terminal half (VN)
(18). Here, when TAPBPR-VC comes into proximity with MHC-
I–VN as the result of protein–protein interactions inside the cell,
an active yellow fluorescent protein can fold resulting in high
BiFC signal, which can be readily detected by flow cytometry. As a
negative control, we used the unrelated protein CXCR4-VN
(C-X-C chemokine receptor type 4), which is not expected to in-
teract with TAPBPR-VC. After gating for cells with similar ex-
pression levels based on intracellular staining of N-terminal
epitope tags (SI Appendix, Fig. S1 A–C), we observed significant
BiFC signal across all H2 and HLA alleles tested, suggesting that a
broad range of MHC-I alleles with diverse sequences have the
potential to interact with TAPBPR in a native cellular environ-
ment (SI Appendix, Fig. S1D). Background BiFC signal for
CXCR4 from nonspecific protein associations is substantially
lower. We note that gating based on expression levels did not
change observed trends, but rather highlighted differences by
excluding high-expressing cells with saturated BiFC signal (SI
Appendix, Fig. S1 A and B). Overexpression of TAPBPR in this
assay also promotes intracellular retention of MHC-I, consistent
with previous reports (6). Unlike the negative control CXCR4, the
MHC-I molecules tested here exhibit severely reduced cell surface
expression in the presence of TAPBPR (SI Appendix, Fig. S1E).
Spontaneous and nonspecific self-assembly of the Venus halves
due to protein overexpression can result in high background and
low signal-to-noise, leading to false-positive BiFC signals for some
protein–protein interactions (18). Thus, we coexpressed and
coimmunoprecipitated TAPBPR with MHC-I in the absence of
VN and VC fusions. Unlike the CXCR4 control, all of the MHC-I
alleles bound TAPBPR, thereby independently confirming the
BiFC results using a different experimental method (SI Appendix,
Fig. S2). Together, these data suggest that TAPBPR associates
with a broad range of MHC-I alleles inside the cell, potentially
through partially folded, empty MHC-I conformations within the
endoplasmic reticulum or Golgi.
TAPBPR Recognizes a Partially Folded Epitope on MHC-I Molecules
with Broad Specificity. Deep mutagenesis, in which directed evolu-
tion of a diverse library of sequences is tracked by next-generation
sequencing, has emerged as a powerful tool for interrogating how
protein amino acid sequence dictates structure and function in
living cells (19). The relative activities of thousands of mutations
can be assessed simultaneously to reveal critical features for pro-
tein stability or ligand binding. To identify important features of
the human MHC-I heavy chain required for TAPBPR association
within cells, we generated a single-site saturation mutagene-
sis (SSM) library on HLA-A*02:01. We chose to focus on
HLA-A*02:01, as it is a common human allele that associates with
TAPBPR in vitro with high affinity and presents several important
autoimmune, viral, and cancer epitopes (4, 7). To improve sam-
pling of individual mutations and thereby increase data quality,
library diversity was limited by restricting mutational scanning to
the MHC-I α1/α2 “platform” domain (residues 2 to 181), which
mediates both peptide and TAPBPR binding (20, 21). Using 2
complementary fluorescence-based selections, we investigated the
effects of single-site mutations throughout the groove on 1) HLA-
A*02:01 cell surface expression, to reveal how particular mutations
influence MHC-I stability, and 2) HLA-A*02:01/TAPBPR recog-
nition, to identify structural elements that are important for
chaperone recognition. There were concerns that high BiFC signal
may simply report on assembly with MHC-I–VN mutants that are
retained in the same intracellular compartments as TAPBPR-VC
(see above). To resolve this potential issue, we used cells stably
expressing a variant called TAPBPR-TM, in which the native
transmembrane (TM) helix and cytosolic tail are replaced with a
generic TM domain. Confocal microscopy (SI Appendix, Fig. S3A)
and flow cytometry (SI Appendix, Fig. S3B) reveal that TAPBPR-TM
localizes intracellularly and at the plasma membrane, and therefore
reports on interactions regardless of whether MHC-I mutants traffic
to the surface or not. Following transfection of the HLA-A*02:01
SSM library and FACS for MHC-I surface expression in wild-type
cells (SI Appendix, Fig. S3C) or MHC-I/TAPBPR BiFC in
TAPBPR-TM-VC–expressing cells (SI Appendix, Fig. S3D), the
relative effects of nearly all single amino acid substitutions in the
MHC-I groove are determined based on their enrichment or de-
pletion (SI Appendix, Fig. S4 A and B). Enrichment ratios of
specific mutations and conservation scores for residue positions
have excellent agreement between independent replicates, pro-
viding high confidence to the mutational landscapes (SI Appen-
dix, Fig. S4 C–G). Processed and raw data are available online
(https://www.ncbi.nlm.nih.gov/geo, GEO accession no. GSE128957;
ref. 22).
We find that surface expression of HLA-A*02:01 imposes
strict sequence constraints throughout the peptide binding
groove, consistent with the preferential trafficking of stable,
peptide-loaded MHC-I to the plasma membrane (Fig. 1 A and B
and SI Appendix, Fig. S4A) (23, 24). Not only are the residues
comprising the MHC-I pockets that anchor the peptide tightly
conserved for surface expression (residues 5, 7, 59, 63, 66, 99,
159, 163, 167, 171 for the A-pocket and 77, 80, 81, 84, 116, 123,
143, 146, 147 for the F-pocket), but so are residues within the
core of the MHC-I groove, and the underlying surface contacting
β2m and the α3 domain (Fig. 1 A–C and SI Appendix, Fig. S4A).
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Fig. 1. TAPBPR recognizes a local conformation of the HLA-A*02:01 α2 domain. (A) Sequence conservation from deep mutagenesis mapped to the surface of
HLA-A*02:01. Conserved residues are colored in dark orange, while residues exhibiting mutational tolerance in pale and blue. Residue conservation for HLA-
A*02:01 surface expression is shown on the structure of the free pMHC-I molecule (PDB ID code 1HHJ), with bound nonamer peptide colored from blue
(residue 1) to red (residue 9). HLA-A*02:01 conservation for TAPBPR (dark green) binding is plotted on the structure of the empty MHC-I, in complex with
TAPBPR (PDB ID code 5WER). The location of the A- to F-pockets of the MHC-I groove are noted. (B) Cross sections through the core of the α2 domain, colored
by conservation as in A. TAPBPR is dark green, β2m is pale green, and the α3 domain is gray. (C) Conservation and variation of residues in the MHC-I pockets
for surface expression (gray) or TAPBPR binding by BiFC (purple). (D–F) Heat maps of mutation log2 enrichment ratios for HLA-A*02:01/TAPBPR BiFC (depleted
mutations are orange, enriched mutations are dark blue) shown alongside modeled structures of the (D) α2 domain/TAPBPR interface, (E) the hydrophobic
core between the α2–1 helix and β-sheet, and (F) the core between the α2–2 helix and β-sheet. (G) Relative BiFC signal between TAPBPR-TM-VC and MHC-I–VN
for different proline substitutions in either the α1 or α2 helices, or β-sheet underlying the α2 helix. (H) Location of proline substitutions on the MHC-I groove
mapped onto the TAPBPR complex structure (PDB ID code 5WER). (I) Relative surface expression for the different MHC-I proline substitutions in the presence
or absence of TAPBPR-TM. (J) Immunoblots comparing total expression levels for TAPBPR-TM (α-FLAG) and HLA-A*02:01 (α-myc) constructs. Lanes are aligned
with graphs above.
25604 | www.pnas.org/cgi/doi/10.1073/pnas.1915562116 McShan et al.
Proper pMHC-I folding and stability in human cells, which ex-
press endogenous tapasin, is therefore intolerant of most single
amino acid substitutions. In an interesting exception to this trend,
sites on the α1 helix (MHC-I residues 67 to 75) that do not par-
ticipate in direct interactions with either the bound peptide or
TAPBPR, but would be engaged by T cell receptors, are more
amenable to mutation (Fig. 1A and SI Appendix, Fig. S4A). Taken
together, these data reveal that conserved MHC-I sites important
for surface expression are dispersed throughout the groove, and
that the most stringent sequence constraints are contained within
the peptide anchoring pockets, consistent with the established
trend that MHC-I surface expression is tightly coupled to proper
peptide loading (23, 24).
While surface expression imposes strict sequence constraints
throughout the MHC-I groove, we find that TAPBPR association
persists following many mutations, and is especially tolerant of
mutations to the 310 and α1 helices that demarcate the α1 domain
of the peptide binding groove (Fig. 1 A–C). This also includes
tolerance to many mutations at positions for which crystallo-
graphically defined intermolecular contacts are observed in the
homologous mouse H2-Dd/TAPBPR complex (21), such as HLA-
A*02:01 residues 83, 84, 127, and 144 (Fig. 1 A and B and SI
Appendix, Fig. S4B). Other HLA-A*02:01 residues that are buried
in the homologous H2-Dd/TAPBPR interface—such as 134, 135,
136, and 148—are under tight sequence conservation (Fig. 1D),
revealing that only a subset of contacts at the MHC-I/TAPBPR
interface are amenable to mutation. While HLA-A*02:01 residues
comprising the A-, B-, and F-pockets of the groove are conserved
for surface expression, they tolerate variability for TAPBPR binding
(Fig. 1C), consistent with TAPBPR engaging HLA-A*02:01 mu-
tants that are defective for peptide loading. There are 2 prominent
buried clusters of conserved MHC-I residues in the mutational
landscape. The first cluster contains HLA-A*02:01 residues from
the region 124 to 147, located within and adjacent to the E- and
F-pockets (Fig. 1 D and E). A second, smaller cluster of MHC-I
residues conserved for TAPBPR binding mediates contacts between
the α2–2 helix and β-sheet around the conserved C101-C164 disul-
fide within the A-pocket (Fig. 1F). We find that mutation of the
C101-C164 disulfide abrogates interaction with TAPBPR, likely
because disulfide bond formation contributes to stabilization of the
α2 domain (25). Elsewhere, HLA-A*02:01/TAPBPR BiFC shows
intermediate mutational tolerance at sites of the MHC-I groove
contacting the β2m/α3 domains, while the core between the α1 helix
and β-sheet has very high mutational tolerance (SI Appendix, Fig.
S4B). Thus, in contrast to the strict sequence conservation of MHC-I
sites dispersed throughout the groove for surface expression, sites
conserved for TAPBPR association are highly polarized toward the
α2 domain of the groove, suggesting that TAPBPR has the potential
to recognize nascent MHC-I molecules with broad sequence spec-
ificity, at least when single amino acid substitutions are considered.
TAPBPR Recognition of Nascent Species Is Polarized toward the α2
Domain of the MHC-I Groove. We hypothesized that TAPBPR can
associate with partially folded or misfolded MHC-I molecules,
with an interaction mode that is dependent upon the formation
of a local conformational epitope adjacent to the α2 helix. Such
MHC-I species likely form intracellularly during the processing of
nascent, peptide-deficient molecules. To investigate this, we cre-
ated a panel of proline substitutions along either the α1 or α2
helices of HLA-A*02:01 groove. Incorporation of a proline is
expected to destabilize secondary structure, especially helices (26,
27). Destabilizing proline substitutions within the α1 helix (I52P,
Y59P, D61P, V67P, D77P, Y84P) do not abrogate BiFC signal
with TAPBPR-TM compared to wild-type HLA-A*02:01, while
those within or adjacent to the α2 helix (G112P, L156P, E166P)
severely reduce BiFC signal with TAPBPR-TM (Fig. 1 G and H).
We simultaneously examined MHC-I surface localization in the
transfected cells. Ordinarily, destabilized MHC-I proline mutants
would not escape intracellular quality control to reach the plasma
membrane, but stable association with TAPBPR-TM, which traf-
fics to the cell surface, is expected to rescue MHC-I surface
localization. Indeed, we find that proline substitutions within the
α1 helix of the groove are able to reach the cell surface only in the
presence of TAPBPR-TM, while those within the α2 helix are
retained intracellularly in the absence and presence of TAPBPR-TM
(Fig. 1I). Importantly, expression of all of the mutants remain at near
wild-type levels, and hence observed differences cannot be explained
by a simple loss of expression (Fig. 1J). Thus, while destabilization of
the HLA-A*02:01 α1 helix induces a misfolded, peptide-deficient
state, these conformations do not compromise the TAPBPR rec-
ognition epitope and a stable complex can form (Fig. 1H). This is in
contrast with proline substitutions within or near to the α2 helix,
which disrupt the local MHC-I structure recognized by TAPBPR
(Fig. 1H).
TAPBPR Recognizes Folded pMHC-I Using a Conserved Binding Mode
of Narrow Specificity. To characterize TAPBPR recognition of
purified pMHC-I molecules in solution, we focused on a repre-
sentative set corresponding to 2 mouse (H2-Dd and H2-Ld) and 2
human (HLA-A*01:01 and HLA-A*02:01) alleles, displaying be-
tween 70% and 85% similarity at the sequence level (SI Appendix,
Fig. S5). Each MHC-I heavy chain was expressed inEscherichia coli
and refolded together with a high-affinity peptide and human β2m
(hβ2m) (7, 28). We utilized well-characterized epitopes: The p29
peptide (YPNVNIHNF) for H2-Ld (29), the HIV gp120 P18-I10
peptide (RGPGRAFVTI) for H2-Dd (30), the neuroblastoma
related NRASQ61K peptide (ILDTAGKEEY) for HLA-A*01:01
(31), and the HTLV-1 TAX peptide (LLFGYPVYV) for
HLA-A*02:01 (32). Using a differential scanning fluorimetry assay
(33), we further confirmed that all purified samples displayed
thermal stabilities that were characteristic of properly conformed,
peptide-bound molecular species with Tm values ranging from 51
to 63 °C (SI Appendix, Table S1). Using a size-exclusion chro-
matography (SEC) assay, we observed formation of pMHC-I/
TAPBPR complexes for both mouse pMHC-I (P18-I10/H2-Dd/
hβ2m and NIH/H2-Ld/hβ2m), but neither of the human pMHC-I
(NRASQ61K/HLA-A*01:01/hβ2m and TAX/HLA-A*02:01/hβ2m)
(Fig. 2A). A potential drawback of SEC is that measurements
carried out under nonequilibrium conditions may favor complex
or peptide dissociation, depending on kinetic off-rates (34). Thus,
we also monitored TAPBPR binding under equilibrium conditions
using solution NMR. Here, we used isotopically AILV-methyl
labeled (Ala 13Cβ; Ile 13Cδ1; Leu 13Cδ1/13Cδ2; Val 13Cγ1/13Cγ2)
pMHC-I (where the hβ2m subunit and peptide are at natural
isotopic abundance), which allows us to quantify specific chemical-
shift changes upon formation of the 87 kDa pMHC-I/TAPBPR
complex (28). NMR can also detect the presence of peptide-
deficient complex in the sample, through the observation of
unique chemical shifts of MHC-I methyl groups of residues in the
peptide-binding groove (28). Toward this goal, we obtained
complete stereospecific assignment for the heavy-chain AILV
methyl groups of each pMHC-I system in our set (28, 35–39).
Simultaneously, to obtain precise thermodynamic parameters de-
scribing the binding process, we performed isothermal calorimetry
titration (ITC) experiments (40). To ensure that the complex
formed with TAPBPR contained exclusively peptide-bound MHC-I
(rather than empty molecules), all ITC experiments were per-
formed in the presence of 10-fold molar excess of free peptide
relative to the pMHC-I (Materials and Methods).
Both NMR and ITC experiments confirm that peptide-bound
TAX/HLA-A*02:01/hβ2m, P18-I10/H2-Dd/hβ2m, and NIH/H2-Ld/
hβ2m form high-affinity complexes with TAPBPR in vitro (Fig. 2 B
and C and SI Appendix, Fig. S6). In NMR experiments, tight com-
plex formation is highlighted by the slow-exchange chemical-shift
changes of resonances corresponding to methyl groups of con-
served heavy-chain residues, such as I124, A211, V231, and V247
McShan et al. PNAS | December 17, 2019 | vol. 116 | no. 51 | 25605
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(Fig. 2B and SI Appendix, Fig. S6), suggesting a similar TAPBPR
binding mode. Peptide release from the pMHC-I/TAPBPR complex
to form an empty complex was not detected under the NMR sample
conditions (Fig. 2B). Whereas the binding footprint of TAPBPR
probed by methyl NMR is highly conserved among the 3 interacting
pMHC-I molecules, and is further consistent with the published
X-ray structures (20, 21), our ITC data reveal that the same complex
structure can be attained via distinct thermodynamic processes.
Specifically, HLA-A*02 exhibits exothermic binding behavior, in
contrast to the endothermic association observed with H2-Dd and
H2-Ld. While the enthalpic (ΔH) and entropic (-T*ΔS) contribu-
tions may differ between HLA-A*02:01 and H2-Dd/H2-Ld, the
resulting binding free energy (ΔG) values are very similar (Fig. 2C).
Fitting of the sigmoidal isotherms using a 1-site interaction model
yields very similar apparent dissociation constants of 2.1 μM
(TAX/HLA*A*02:01/ hβ2m), 3.1 μM (P18-I10/H2-Dd/hβ2m),
and 3.0 μM (NIH/H2-Ld/hβ2m) (Fig. 2C). Notably, NRASQ61K/
HLA-A*01:01/hβ2m does not interact with TAPBPR by either
SEC, NMR, or ITC, up to millimolar-range concentrations (Fig.
2 and SI Appendix, Fig. S6). Together, our biophysical data re-
veal that relative to the broad specificity exhibited toward MHC-
I molecules of different sequences inside the cell (SI Appendix,
Figs. S1 and S2), TAPBPR recognizes properly conformed,
peptide-loaded MHC-I molecules with a narrow specificity in
Fig. 2. TAPBPR interactions with peptide-loaded MHC-I molecules are allele-dependent. (A) SEC traces of 1:1 molar ratio of TAPBPR with different pMHC-I
heavy chains, each refolded with human β2m and a high-affinity peptide. (B) Representative 2D 1H-13C HMQC spectra of heavy-chain 13C AILV methyl labeled
pMHC-I at 105 μM without TAPBPR (gray) and in the presence of 3-fold molar excess TAPBPR. From left to right: NRASQ61K/HLA-A*01:01/hβ2m (orange), TAX/
HLA-A*02:01/hβ2m (blue), P18-I10/H2-Dd/hβ2m (green), and NIH/H2-Ld/hβ2m (purple). Experiments were performed at a 1H NMR field of 800 MHz at 25 °C.
Arrows indicate significant chemical-shift changes in MHC-I heavy-chain NMR resonances upon TAPBPR binding. (C) Representative ITC data titrating ∼100 to
150 μM pMHC-I (from Left to Right: NRASQ61K/HLA-A*01:01, TAX/HLA-A*02:01, P18-I10/H2-Dd, and p29/H2-Ld) into a sample containing 12 μM TAPBPR and
1 mM peptide. Black lines are the fits of the isotherm. Fitted values for KD, ΔH, -TΔS, and ΔG were determined using a 1-site binding model. n.d., not de-
termined. Errors were determined from experimental replicates (n = 2).
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solution, even when comparing pMHC-I complexes that are very
similar in terms of overall fold, amino acid composition, and
thermal stability.
pMHC-I Molecules Exhibit Allele-Specific Conformational Dynamics.
Conformational dynamics have been implicated in several as-
pects of MHC-I function, including peptide loading, T cell re-
ceptor triggering, and chaperone recognition (2, 41, 42). Solution
NMR allows the quantitative measurement of dynamics across
biologically relevant timescales ranging from picosecond to
nanosecond (sidechain and loop motions), microsecond to mil-
lisecond (minor domain movements), to seconds (major domain
reorientation) (43). Previous NMR measurements of picosecond
to nanosecond dynamics in pMHC-I molecules did not uncover
molecular flexibility other than in flexible loop regions (28, 44).
In contrast, MHC-I regions involved in peptide and chaperone
recognition exhibit microsecond to millisecond exchange be-
tween major and minor conformational states (28, 45). We have
previously established the use of methyl groups as highly
sensitive NMR probes with widespread coverage of the entire
MHC-I structure to characterize unchaperoned and chaperoned
MHC-I complexes (28).
Here, we have adopted a similar approach to quantitatively
compare and contrast conformational dynamics in our repre-
sentative set of pMHC-I molecules of different allelic composi-
tion, toward uncovering differences that could explain varia-
tion trends in TAPBPR recognition. We examined dynamics of
AILV methyl groups of unchaperoned pMHC-I (where the heavy
chain is isotopically labeled, while hβ2m and the peptide are at
natural isotopic abundance) using 13C single-quantum Carr-
Purcell-Meiboom-Gill (13C-SQ CPMG) relaxation dispersion
NMR experiments (45, 46). In these experiments, methyl groups
undergoing conformational exchange at the microsecond to
millisecond timescale exhibit marked changes in the measured
effective relaxation rate (R2
eff) as a function of the frequency of
the refocusing pulses (νCPMG) (43, 46). For each pMHC-I, we
acquired 13C-SQ CPMG relaxation dispersion data at 25 °C at
2 NMR field strengths (600 MHz/14.1 Tesla and 800 MHz/18.8
Tesla). All AILV methyl groups with observable dynamics (Rex >
1 s−1) were fit to a 2-state exchange model (Fig. 3A). This pro-
cedure allowed us to extract quantitative NMR parameters that
report on conformational exchange, including the exchange rate
constant (kex = kAB + kBA), populations of the major and minor
states (pA and pB) and absolute values of the
13C chemical-shift
differences between the minor and the major state (jΔωj) (43,
46). CPMG experiments were performed in the presence of 3-
fold molar excess of peptide to minimize the population of
aggregation-prone empty MHC-I, as the half-lives of moderate
to high-affinity peptides have been reported in the 0.3- to 28-h
range (47–49). Specifically, we found no significant difference in
the CPMG profiles and derived parameters in experiments
performed for HLA-A*02:01 in the absence or presence of ex-
cess TAX peptide (SI Appendix, Fig. S7), suggesting that the
excited state observed in our CPMG experiments does not cor-
respond to a transition between the peptide-bound and peptide-
free form, but rather to a conformational change occurring while
the peptide remains bound in the MHC-I groove.
We observed conformational exchange at pMHC-I sites important
for function, including the α2–1 helix, the β5-β8 sheet forming the floor
of the groove, the A-pocket, and α3 domain. Notably, all CPMG
profiles of methyl resonances showing conformational exchange
Fig. 3. Dynamic profiles of different pMHC-I molecules probed by methyl NMR. (A) Summary of microsecond to millisecond timescale conformational ex-
change of peptide-bound MHC-I molecules between a major, ground state and a minor, excited state. Experimentally determined populations of the major
and minor states and the exchange rate (kex) are noted in SI Appendix, Table S2. (B) Comparison of jΔωj values obtained from a global fit of CPMG data for all
sites together (x axis) or independent fits of each site (y axis), shown for methyl groups in the groove (black) or α3 domain (cyan). (C–F) The sites that
participate in the global conformational exchange process are represented as spheres on the structure of each pMHC-I viewed from the side (Upper) or above
the groove (Lower). hβ2m is omitted for clarity. (C) NRASQ61K/HLA-A*01:01/hβ2m (PDB ID 6MPP), orange; (D) TAX/HLA-A*02:01/hβ2m (PDB ID code 1DUZ) (32),
blue; (E) P18-I10/H2-Dd/hβ2m (PDB ID code 3ECB) (30), green; and (F) NIH/H2-Ld/hβ2m (PDB ID code 1LD9) (29), purple. Methyl groups undergoing dispersion
are shown as spheres and color-coded based on jΔωj values obtained from a global fit of each pMHC-I. Methyl sites of increased dynamics are shown with
warmer colors.
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could be individually fit to a model yielding the same population and
kinetic parameters (Fig. 3B), suggesting the presence of a global
conformational change connecting disparate sites on the MHC-I
structure. However, the extent of dynamics within the different
MHC-I domains was allele-dependent. While all pMHC-I molecules
displayed A-pocket dynamics (Fig. 3 C–F, residue 28, and SI Ap-
pendix, Fig. S8A), α2–1 helix dynamics were only observed in the 3
pMHC-I molecules recognized by TAPBPR (Fig. 3 C–F, residue 150,
and SI Appendix, Fig. S8B). In addition, microsecond to millisecond
conformational exchange in the α3 domain was only observed for
pMHC-I molecules prepared with mouse heavy chains H2-Dd or
H2-Ld (Fig. 3 C–F, residue 231, and SI Appendix, Fig. S8C). In all
molecules, methyl groups span the entire length of theMHC-I groove
and α3 domain, thus a lack of observed dynamics is not due to in-
complete probe coverage (SI Appendix, Fig. S9). Following a global
fitting procedure of all methyl sites in each molecule, we obtained kex
values ranging from 976 to 1,700 s−1 and pB values between 3.2% and
5.4% (SI Appendix, Table S2). Fitted jΔωj values range between 0.2
and 1.3 ppm (Fig. 3 D–F and SI Appendix, Table S2). In summary,
our CPMG data revealed unique allele-specific, dynamic profiles of
unchaperoned pMHC-I molecules, for which differences were more
pronounced at functionally relevant sites located within the α2 helix
and α3 domain.
A Minor Conformational State Underpins TAPBPR Recognition of
Different MHC-I Alleles. To confirm that TAPBPR utilizes a con-
served overall binding mode to recognize pMHC-I molecules of
different allelic compositions, we performed a chemical-shift
deviation (CSD) analysis for complexes prepared using labeled
HLA-A*02:01 and H2-Ld heavy chains, in addition to our pre-
vious characterization of H2-Dd (28). Here, the directly observed
chemical shifts of the TAPBPR-bound state serve as unique
identifiers of the induced local conformational changes, relative
to the free pMHC-I state, for each residue. Using our established
AILV methyl assignments for each system, the measured CSDs
reveal that the same surfaces spanning multiple MHC-I domains
on peptide-loaded H2-Dd, H2-Ld, and HLA-A*02:01 are en-
gaged to form tight complexes with TAPBPR, consistent with the
peptide-deficient MHC-I/TAPBPR crystal structures (20, 21, 28)
(Fig. 4 A and B). Specifically, the NMR resonances corre-
sponding to equivalent methyl probes in the α1 helix (residues 28
to 76), the β5-β8 strands (residues 104 to 130), the α2–1 helix
(residues 139 to 158), and α3 domain (residues 230 to 251) of the
heavy chain show significant CSDs upon TAPBPR binding
across the 3 pMHC-I molecules analyzed here (Fig. 4 A and B).
Our previous NMR study of the H2-Dd system suggested that
MHC-I surfaces exhibiting microsecond to millisecond confor-
mational dynamics in solution correlate with the TAPBPR rec-
ognition sites (28). To investigate whether this is a general trend,
we compared heavy-chain methyl groups displaying signifi-
cant chemical shift changes upon complex formation (deter-
mined from NMR titrations) with those exhibiting microsecond
to millisecond conformational exchange in the unchaperoned
pMHC-I (determined from CPMG experiments). A compari-
son of the absolute value of the difference between the 13C
chemical shifts (jΔ13Cδj) of the unchaperoned and TAPBPR-bound
pMHC-I states versus jΔωj values, obtained from fits of CPMG
Fig. 4. Dynamic surfaces of pMHC-I structures correlate with TAPBPR recognition sites. (A) Methyl CSDs upon chaperone binding plotted onto the structure
of MHC-I/TAPBPR complexes: TAX/HLA-A*02:01/hβ2m (blue), P18-I10/H2-Dd/hβ2m (green), and NIH/H2-Ld/hβ2m (pink) with TAPBPR shown in gray. The H2-Dd/
TAPBPR crystal structure was obtained from PDB ID 5WER. The other structures are Rosetta homology models using PDB ID 5WER as a template (70). Affected
regions are labeled. ΔCSDs are colored based on the scale shown at right. (B) Methyl CSDs measured from NMR titration experiments upon TAPBPR binding
are shown as a function of heavy-chain methyl residue number. Select methyl groups affected are noted. The gray dotted line represents the average CSD + 1
SD. (C) The absolute value of the difference in the 13C chemical shift of the major and minor states of unchaperoned pMHC-I obtained from CPMG relaxation
dispersion data (jΔωj, ppm) is shown as a function of the absolute value of the difference in the 13C chemical shift between the free and TAPBPR bound pMHC-
I states determined from NMR titrations (jΔδ13Cj, ppm). The slope (dotted gray line), the Pearson correlation coefficient (r), and the root mean square de-
viation (r.m.s.d.) are given for each correlation graph. The correlations are statistically significant with a P < 0.0001. HLA-A*01:01 is not included because there
is no detectable TAPBPR binding under the NMR sample conditions (see Fig. 2).
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dispersion profiles of free pMHC-I, uncovers a strong positive
correlation (R2 0.85 to 0.87) (Fig. 4C). Any conformational change
in the pMHC-I induced by TAPBPR binding therefore occurs on
pMHC-I surfaces of considerable structural plasticity in the free
pMHC-I state.
Moreover, given that the jΔωj values directly report on con-
formational changes upon formation of a minor (3 to 6% pop-
ulation) state sampled by free pMHC-I molecules in an aqueous
solution, our observed quantitative correlation of jΔ13Cδj with
jΔωj supports a plausible model where the minor state is directly
recognized by TAPBPR to form an initial encounter complex.
Further structural adaptations, induced by direct interactions
between the 2 proteins, then lead to the formation of the final,
tight complex with each pMHC-I molecule. Since the extent of
MHC-I regions participating in the formation of the minor state
vary between MHC-I molecules of different heavy-chain com-
position (Fig. 3 C–F), with the noninteracting heavy-chain HLA-
A*01:01 exhibiting the most restricted dynamics, this model can
explain allelic dependencies by differences in the minor state
conformation.
Restriction of the α2–1 Helix Abrogates Sampling of the Minor State
and TAPBPR Recognition. Our data, in conjunction with previous
reports (42), provide strong evidence that the conformational
plasticity of MHC-I molecules plays a key role in chaperone
recognition. TAPBPR binding persists within the cell even in the
presence of many disruptive mutations to the α1 domain, dem-
onstrating that nascent MHC-I substrates for TAPBPR may be
partially folded, with a high degree of conformational entropy
(SI Appendix, Fig. S4 A and B). To further test this model in a
controlled manner, we attempted to engineer an MHC-I mole-
cule of restricted groove mobility. Such an engineered variant
should also be stable for purification and detailed biophysical
characterization in solution. We borrowed a design strategy
previously applied to mouse H2-Kb to demonstrate that stabili-
zation of the groove can rescue cell surface expression in a
functional tapasin knockout (50, 51). A mutant MHC-I molecule,
H2-Dd Y84C-A139C, was prepared with an engineered disulfide
between the sidechains of residues 84 and 139 across the F-pocket,
which restricts the accessible conformational space for the MHC-I
groove. Mouse H2-Dd was chosen as it is closely related to H2-Kb,
displays tight TAPBPR affinity in biophysical experiments, and
finally because H2-Dd can still traffic to the plasma membrane
when overexpressed together with suitable TAPBPR constructs.
This property further allows us to distinguish between interactions
with nascent intracellular MHC-I versus folded pMHC-I that es-
capes to the cell surface. By comparison, HLA-A*02:01 is retained
internally (possibly in a nascent form) when coexpressed with
TAPBPR (SI Appendix, Fig. S3 A and B). Soluble H2-Dd Y84C-A139C,
prepared as a complex with the P18-I10 peptide and human β2m,
has comparable thermal stability to the wild-type molecule, sug-
gesting that the disulfide does not compromise the pMHC-I
structure (SI Appendix, Table S1). Finally, we solved the crystal
structure of the P18-I10/H2-Dd Y84C-A139C/hβ2m complex at 2.37-Å
resolution (SI Appendix, Table S3, PDB ID 6NPR; ref. 52), which
confirmed the presence of the oxidized C84-C139 disulfide bond,
bound P18-I10 peptide, and that the structure is very similar to the
wild-type molecule (Fig. 5 A–C).
As predicted by our model, H2-Dd Y84C-A139C exhibits 15-fold
lower affinity for TAPBPR relative to wild-type P18-I10/H2-Dd/
hβ2m by line-shape analysis of NMR titrations performed using
the program TITAN (Fig. 5 D and E). The impaired interaction
with TAPBPR is due to the presence of the C84-C139 disulfide,
since specific reduction of this exposed disulfide with 1 mM of
the mild reducing agent Tris(2-carboxyethyl)phosphine (TCEP),
further confirmed by NMR, rescues TAPBPR binding (Fig. 5F).
As expected, the methyl chemical shifts of reduced H2-Dd Y84C-A139C/
TAPBPR complexes show no observable differences relative to
the wild-type sample, suggesting that addition of small amounts
of mild reducing agent does not affect the conserved MHC-I
disulfide bonds between C101-C164 and C203-C259, located at
the buried interface of the α2 helix with the MHC platform and
core of the α3 domain, respectively (Fig. 5 D–F). In contrast to
wild-type H2-Dd, the disulfide-linked molecule demonstrates high
levels of peptide exchange in fluorescence anisotropy experiments
performed using a TAMRA-linked version of the P18-I10 peptide,
even in the absence of TAPBPR (Fig. 5G), in agreement with
recent reports that the same disulfide design approach can stabi-
lize empty MHC-I molecules for a range of allelic compositions
(50, 51). Notably, 13C-SQ CPMG relaxation dispersion experi-
ments of P18-I10/H2-Dd Y84C-A139C/hβ2m under the identical
NMR conditions to experiments performed using wild-type H2-
Dd clearly show that microsecond to millisecond conformational
dynamics are quenched throughout the entire MHC-I structure,
including the A-pocket, α2–1 helix, and α3 domain regions, which
exhibit clear dispersion profiles in the wild-type molecule (Fig. 5
H–J). Together, these results further support our model of
TAPBPR recognition through a network of dynamically coupled
surfaces spanning multiple domains.
To complement these conclusions with experiments in the na-
tive cellular environment, tagged TAPBPR and H2-Dd constructs
were coexpressed in human Expi293F cells. H2-Dd Y84C-A139C
coimmunoprecipitated with TAPBPR similarly to wild-type H2-
Dd (SI Appendix, Fig. S10), despite showing reduced binding in
the NMR experiments described above. Whereas binding inter-
actions measured by NMR utilized purified, properly conformed
H2-Dd Y84C-A139C in complex with the high-affinity P18-I10 pep-
tide, within the cell nascent, empty MHC-I progressing through the
secretory pathway are likely partially folded and exposing reduced
cysteines. This effect is further pronounced under our over-
expression conditions, leading to increased protein concentrations
in the endoplasmic reticulum. To resolve TAPBPR interactions
with nascent/misfolded versus properly conformed MHC-I spe-
cies, we compared wild-type TAPBPR to the TAPBPR-TM vari-
ant that can traffic to the plasma membrane, and measured
interactions by BiFC. In agreement with the coimmunoprecipitation
experiments, H2-Dd Y84C-A139C shows slightly enhanced BiFC with
intracellular TAPBPR (Fig. 6 A, Left), presumably due to associa-
tions with nascent, partially reduced H2-Dd Y84C-A139C (Fig. 6B)
(5). However, when folded H2-Dd Y84C-A139C molecules harboring
a stabilizing disulfide are localized to the plasma membrane, as-
sociation with TAPBPR-TM is substantially reduced, in agree-
ment with our solution NMR results (Fig. 6 A, Center).
Discussion
Our combined results suggest that TAPBPR has the capacity for
multiple cellular functions: 1) A molecular chaperone of desta-
bilized, empty MHC-I molecules at early stages of their folding
process with broad substrate sequence specificity, and 2) a
peptide editor acting on properly conformed, peptide-loaded
MHC-I molecules with a more exclusive specificity range (Fig. 7).
The chaperone function may provide an important protein ho-
meostasis mechanism, by stabilizing misfolded, aggregation-
prone MHC-I species that form inside the cell (5, 53, 54) and
are known to contribute to the onset of disease (55). This cellular
function is often attributed to a class of generic chaperones
known as “holdases” that includes essential heat-shock proteins
(56). Our deep mutagenesis data suggest that TAPBPR has the
capacity to function as a holdase by chaperoning the minimally
folded epitope on the MHC α2 domain with a conserved disul-
fide (Fig. 7), which is further consistent with the observed
TAPBPR associations of a large panel of diverse MHC-I se-
quences and destabilizing mutants tested here. Such a putative
holdase function of TAPBPR can be further addressed in protein
trafficking studies, aiming to reveal a positive effect on the
maturation of MHC-I allotypes whose bound peptides are
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generally not edited by TAPBPR, such as HLA-A*01:01. The
role of the “editing” mode is likely to further scrutinize the
peptide cargo of properly conformed MHC-I molecules during
their egress to the cell surface. In this manner, TAPBPR helps to
“focus” the antigen repertoire toward higher-affinity peptides,
such that pMHC-I molecules displayed at the cell surface exhibit
sufficient stability and lifetime for immune recognition (4, 5, 57,
58). In contrast to chaperoning activity, the editing function of
TAPBPR exhibits a narrow specificity range, where recognition
of pMHC-I molecules is mediated by an excited state of 3 to 6%
population in solution. This state is attained via a global
conformational transition of the pMHC-I molecule as a whole
through a network of allosterically coupled sites spanning both
ends of the MHC groove and on the α3 domain. While the exact
Fig. 5. Restriction of dynamics in the pMHC-I groove abrogates binding to TAPBPR. (A) View of the P18-I10/H2-Dd Y84C-A139C/hβ2m complex solved at 2.4-Å
resolution (PDB ID code 6NPR). The H2-Dd heavy chain is colored green, hβ2m cyan and P18-I10 magenta. The oxidized disulfide bond between C84 and C139
of H2-Dd is shown in yellow. (B) Overlay of the MHC-I groove (residues 1 to 180) and bound P18-I10 peptide for wild-type H2-Dd (PDB ID code 3ECB, gray) and
H2-Dd Y84C-A139C (colored as in A). The α3 domain and hβ2m are omitted for clarity. Backbone r.m.s.d. over the entire pMHC-I is 1.4/1.7 Å; (backbone/all-atom).
(C) View of the P18-I10/H2-Dd Y84C-A139C structure showing the 2Fo − Fc electron density map at 1.0 σ (gray mesh) around the P18-I10 peptide (magenta) and
C84-C139 disulfide bond (yellow). (D–F) Representative 2D 1H-13C HMQC spectra from NMR titrations between TAPBPR and isotopically labeled (at the heavy
chain) (D) wild-type P18-I10/H2-Dd/hβ2m, (E) P18-I10/H2-Dd Y84C-A139C/hβ2m, and (F) P18-I10/H2-Dd Y84C-A139C/hβ2m in the presence of 1 mM TCEP. The NMR
spectra shown were performed with 3-fold molar excess TAPBPR. Dissociation constants obtained from NMR line shape fitting in TITAN are noted. (G)
Fluorescence anisotropy experiments comparing exchange of TAMRA-labeled P18-I10 peptide with wild-type H2-Dd and H2-Dd Y84C-A139C as a function of
TAPBPR concentration. (H–J) Comparison of representative 13C-SQ CPMG relaxation dispersion profiles for methyl groups of the heavy chain between wild-
type P18-I10/H2-Dd/hβ2m (800 MHz, blue; 600 MHz, purple) and P18-I10/H2-Dd Y84C-A139C/hβ2m (800 MHz, yellow; 600 MHz, green) performed at 25 °C. Both
experiments were performed in the presence of 3-fold molar excess P18-I10 peptide.
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nature of the MHC-I conformations recognized by the chaper-
one and editing functions of TAPBPR remains to be fully de-
scribed, our studies provide evidence that dynamics of the α2
domain are important for both recognition events. We propose
that the chaperone and editing functions of TAPBPR have the
same underlying structural basis. Based on crystal structures,
TAPBPR binds to a conformation of the MHC-I α2 domain
encompassing a widened groove. Nascent MHC-I molecules will
readily sample multiple conformations, including those recog-
nized by TAPBPR. However, as the MHC-I folds and binds to
peptides, only MHC-I molecules that retain dynamic motions
will sufficiently sample conformations selectively recognized by
TAPBPR (Fig. 7). This property of pMHC-I molecules is defined
both by the allelic composition of the heavy chain and the
bound peptide.
Dynamic sampling of different MHC-I states has been pre-
viously suggested to be affected by both the bound peptide and
the identity of amino acid sidechains in the D-, E-, and F-pockets
(13, 14, 59). Polymorphisms at specific positions—such as 114,
116, 147, and 156—have been shown to confer chaperone rec-
ognition of different alleles, due to these sites modulating the
conformational flexibility and stability of peptide-deficient MHC-I
(9, 59, 60). A sequence alignment of MHC-I molecules that rec-
ognize TAPBPR (H2-Dd, H2-Ld, HLA-A*02:01) versus 1 that does
not (HLA-A*01:01) leads to no obvious clues to chaperone
recognition, as the sites forming D-, E-, and F-pockets for
HLA-A*02:01 and HLA-A*01:01 are highly conserved (SI
Appendix, Fig. S5). Thus, future MD simulation experiments
validated through measurements of dynamics by NMR and other
biophysical techniques will be invaluable in understanding the exact
molecular determinants that regulate MHC-I dynamics, given that
protein dynamics involve transitions between multiple conforma-
tional basins with relatively low energy barriers, which can shift
drastically in the presence of mutations due to allosteric effects (61).
A limitation of the present study is that the panel of heavy-
chain molecules tested has a very limited coverage of the more
than 8,000 unique HLA sequences reported in the Immuno
Polymorphism Database-International IMmunoGeneTcs Data-
base (IPD-IMGT)/HLA database (62). Additional experi-
ments are needed to establish functionally important trends for
TAPBPR across the human HLA allelic landscape, including the
HLA-B and HLA-C classes (63). Equally important features of
the MHC-I that contribute to the sequence-specificity of chaper-
one recognition remain to be characterized. First, with respect to
the editing function of TAPBPR, bound peptides are known to
contribute to the dynamic network on MHC-I structure (28, 64,
65). Second, the β2m light chain contributes to peptide binding,
stabilization of the MHC-I groove, and forms direct contacts with
Fig. 6. Restriction of MHC-I dynamics diminishes TAPBPR association on a
cell membrane. (A) Cells were cotransfected with VC-fused FLAG-TAPBPR
(Left), FLAG-TAPBPR-TM (Center), or FLAG-CXCR4 (Right), and with VN-
fused myc-H2-Dd or myc-CXCR4. Yellow fluorescence (shown as average
Δmean fluorescence units ± SD, n = 4) was measured after gating for
equivalent expression levels. P values are calculated from 2-tailed Student’s
t test. n.s., not significant. (B) Nascent MHC-I (step 1) within intracellular
compartments associates with quality control machinery. The presence of
additional, partially reduced cysteines is hypothesized to enhance chaperone
associations, including direct or indirect recruitment of TAPBPR. As MHC-I
completes its folding, it may transiently interact with TAPBPR (step 2) before
mature pMHC-I traffics to the plasma membrane (step 3). The stabilizing
disulfide diminishes direct interactions between folded pMHC-I molecules
and TAPBPR.
Fig. 7. Chaperone recognition of a dynamic MHC-I conformational land-
scape. Conceptual example of the interaction between the chaperone
TAPBPR and different MHC-I conformations of varying energetic and struc-
tural features. The vertical axis is free energy and the horizontal axis rep-
resents the conformational landscape of the MHC-I, which is influenced by
specific polymorphisms in the MHC-I groove (α1/α2) and α3 domains. (A)
TAPBPR does not associate with an MHC-I state comprising a misfolded α2
domain (red). (B) In the chaperoning function, TAPBPR interacts with nascent
MHC-I conformations consisting of a folded α2 domain (light green) with an
oxidized disulfide bond between the conserved Cys-101/164, even if the α1
domain remains in a misfolded state (red). (C) As a peptide editor, TAPBPR
recognizes properly conformed molecules loaded with peptides toward ex-
change of the bound peptide cargo, for those alleles that exhibit μs-ms time
scale conformational dynamics at the α2–1 helix (green). The peptide in the
properly conformed pMHC-I state is shown as blue spheres.
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TAPBPR (20, 21, 28). Although this is not addressed here,
TAPBPR might also chaperone MHC-I molecules prior to their
association with β2m, in a similar manner to tapasin (66). In our
biophysical characterization of MHC-I/TAPBPR association, both
human and mouse MHC-I molecules were prepared with human
β2m. It remains unclear how heavy-chain interactions with human
versus mouse β2m, known to exhibit differences in affinity for the
heavy chain, may modulate activity of the editing mode of
TAPBPR (67). Furthermore, MHC-I molecules that are prepared
in E. coli lack important glycan modifications present in vivo,
which could further contribute to chaperone recognition, either
via direct interactions or due to changes in the dynamic landscape
of the MHC-I (68, 69). Finally, we have interpreted our cellular
data on the basis of direct interactions between TAPBPR and
MHC-I, due to their known physical association and because the
HLA-A*02:01 mutational landscape is consistent with crystal
structures. However, we cannot yet definitively rule out that allele
specificity is broadened within the cell due to indirect associations
mediated by higher-order chaperone assemblies.
In summary, our data provide insights into the conformational
plasticity of different MHC-I molecules by a range of techniques,
and suggest a plausible role of these coupled motions in shaping
the allelic specificity of TAPBPR recognition. The conserved
MHC-I recognition mechanism shared between TAPBPR and
tapasin implies that a similar paradigm of dynamically driven
recognition may also influence MHC-I allelic dependencies for
tapasin in the peptide-loading complex. These findings are a first
step in elucidating how molecular chaperones selectively edit the
displayed antigen repertoire for different alleles, toward un-
derstanding their role in the highly complex associations between
HLA polymorphisms and human diseases.
Materials and Methods
Specific details about protein expression and purification, ITC experiments,
NMR assignments, chemical-shift mapping and CPMG relaxation dispersion
experiments, X-ray crystallography, fluorescence anisotropy, coimmunopre-
cipitation/immunoblots, and BiFC/deep-sequencing assays are outlined in
detail in the SI Appendix.
Data and Materials Availability. Raw and processed Illumina sequencing data
are deposited with National Center for Biotechnology Informaton’s Gene Ex-
pression Omnibus under series accession number GSE128957. NMR assignments
have been deposited into the Biological Magnetic Resonance Data Bank (http://
www.bmrb.wisc.edu) under accession numbers 27249 [H2-Dd], 27682 [H2-Ld],
27632 [HLA-A*01:01] and 27631 [HLA-A*02:01]. The atomic coordinates and
structure factors for the P18-I10/H2-Dd Y84C-A139C/β2m complex have been de-
posited in the Protein Data Bank (https://www.rcsb.org/) under the PDB ID code
6NPR. Plasmids are available from Addgene (https://www.addgene.org).
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